These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 18167288)

  • 1. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the diagnostic value of plasma endothelin for diabetic retinopathy using the receiver operating characteristic curve.
    Zhu H; Shi CH
    Ophthalmic Res; 2007; 39(5):289-93. PubMed ID: 17851270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
    Lee IG; Chae SL; Kim JC
    Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The abnormal reaction to post methionine loading test in type diabetes with or without retinopathy].
    Guo Q; Lu J; Pan C
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):725-8. PubMed ID: 12126538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus].
    Ermakova NA; Syrodeeva ON; Antsiferov MB; Balatskaia NV; Krasnova LB
    Vestn Oftalmol; 2008; 124(1):25-8. PubMed ID: 18318205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
    Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
    Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
    De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
    Zhou H; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An epidemiological study on diabetic retinopathy among type 2 diabetic patients in Shanghai].
    Hu HY; Lu B; Zhang ZY; Mao LY; Song XY; Dong XH; Yang YH; Zhou LN; Li YM; Zhao NQ; Zhu XX; Wang XC; Ye HY; Hu RM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Sep; 28(9):838-40. PubMed ID: 18251261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy.
    Zakareia FA; Alderees AA; Al Regaiy KA; Alrouq FA
    J Diabetes Complications; 2010; 24(3):179-85. PubMed ID: 19216096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
    Awata T; Kurihara S; Takata N; Neda T; Iizuka H; Ohkubo T; Osaki M; Watanabe M; Nakashima Y; Inukai K; Inoue I; Kawasaki I; Mori K; Yoneya S; Katayama S
    Biochem Biophys Res Commun; 2005 Aug; 333(3):679-85. PubMed ID: 15963467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.